patients will be at 25%. 7. Table 2 : Maybe discuss the trend for the MS group to have more SA and DP benefits 7 years prior to diagnosis? 8. Table 4 : For the non specialist, it may be worthwhile to explain why the totals of SA, DP and earnings don't add up, i.e. gross vs net after tax. 9.
Numbers: I don't know whether presenting SEK by 100s is usual -I would find by 1000s more usual and readable, i.e. 199 instead of 1994. 10.
Some strengthening of the extreme skewedness of the data would be helpful for the reader (most medians are zero). Maybe cite the % from table 2 in the text? 11.
Finally, page 12 lines 37-8: suggest to delete that sentence, as in view of the skewedness of the data this could be misleading. 12. Finally, suggest to replace reference 6 with the reference to Brundin et al, MS Journal, supplement August 2017. Similar data, but more recent.
VERSION 1 -AUTHOR RESPONSE

Editors' comments:
Please improve the reporting of the statistics throughout your abstract. For example, please include costings, values and 95% CI in the abstract where appropriate.
Authors' response: Thank you for this suggestion. We have now included the estimated values for the differences in the various types of incomes between the people with MS and references without MS throughout the results section in the abstract (Lines 38-45). All differences are in Swedish Krona (SEK) and with 95% confidence intervals (95% CI). Accordingly, we updated Table 2 to include 95% CI with Satterthwaite (assuming unequal variances) 95% CI for these differences, rather than the pvalues previously presented. A range of p-values to illustrate the finding of no differences in disposable income between the study groups for all 12 follow-up years are provided to efficiently present this information (Lines 39 and 255). We believe that the inclusions as recommended have improved the reporting of our findings in the abstract and provide more specific results.
Reviewer comments to the author: Reviewer Name: Gisela Kobelt This is a very interesting and well written study of the development of individual disposable income around the time of diagnosis of MS in Sweden. It essentially shows that during the very first years of MS, transfer payments not surprisingly compensate fully any potential loss of income. I have some minor comments and suggestions.
1.
The title is misleading despite its length. This is not about the entire MS population, and the full duration of the disease. Suggest modifying to make it clearer. Authors' response: Thank you for this valuable comment! In line with your comments, we amended the manuscript's title. We believe the title now better reflects and communicates the content of the manuscript to the potential readers. Within the title we added both elements suggested: 'working ages' to clarify the sub-section of the MS population we have focused on in the current work; and an indication of the length of time we observed the incomes for, through adding the length of time in both the pre-and post-diagnosis periods we observed. Accordingly, our new title is: 'Trajectories of disposable income among people of working ages diagnosed with multiple sclerosis: A nationwide register-based cohort study in Sweden 7 years before to 4 years after diagnosis with a population-based reference group' 2.
The only major comment is that the abstract is misleading as it is too generic. The authors need to make it clear that only the first 4 years after diagnosis (i.e. officially with MS) are included in the abstract as well. Authors' response: Thank you for highlighting the need to rework the abstract, given its importance in communicating the study to potential readers. In reflection of both the reviewer and editor's comments on the abstract, the abstract was revised to improved readability and clarity. In particular, the results and conclusions were revised, and in line with the editors' suggestions specific values of the estimated differences are reported in the results (lines 39-45). We hope our edits have expressed the time limitation more clearly. We have incorporated the time span of our manuscript in the objectives, elaborated more within the design, and concluded on our findings in the short-term perspective we observed. In addition, we added the working-age focus as suggested as our findings are for this population group. This focus is now explicit in the objectives and setting, and conclusions made for this population group. By reworking the results to add specific statistics and values, as well as tailoring the conclusion to better reflect the aim to study the economic welfare of working aged individuals around the years proximate to diagnosis, we believe that the abstract is now less generic and provides an accurate summary of our study. Furthermore, we conclude that our findings in light of the literature suggest that the reductions in economic welfare, as measured by disposable income, are delayed in manifesting at the group level, and future studies with modern cohorts are required to see when and the magnitude of the differences that may appear.
3.
It may also be beneficial to strengthen this more in the introduction and discussion. The economic impact of MS on individuals sets in later in the disease, as careers get destroyed and DP does not compensate to the same extent as SA. Maybe some of the progression studies (e.g. Confavreux in Brain, time to 4, 6, 7 EDSS) could be used for discussion?
Authors' response: Thank you for this comment highlighting the need to strengthen and clarify these important points which underpin the interpretations of our findings.
We edited the introduction to increase flow and clarify. As suggested, we added early to the introduction the reference to Brundin 2017 in reference to the survey results that people with MS experiencing increasing absenteeism and presentism, ie careers suffer (Lines 74-78). Furthermore, we added reference to the literature with findings of associations of physical disability (EDSS) and cognitive function to the sickness absence and disability pension benefits linking progression to these benefits for morbidity related absences. Confarvreux et al was also used in the introduction to strengthen mention of the variability in progression of MS (Lines 76-77).
The discussion, especially the interpretations of findings section, was revised to center around the short-term observation of our study in the context of a progressive disease likely to worsen over time, with reference to the suggested progression study (334) (335) (336) (337) . Accordingly, we hope the discussion is more clearly indicating that with further progression of MS disability (physical and cognitive), the levels of work incapacity are likely to increase to allow for observation of changes in the different income sources in light of the Danish findings and how the disability pension reimbursement is a lower proportion of previous earnings.
When revising the discussion, we made reference to additional studies: Kavaliunus et al 2017 (Lines 329-332) on cognitive function associated with work disability, and Gyllensten et al 2016 which also looked at changes in work disability with a similar period of follow-up before and after diagnosis was used to discuss our trends in increasing sickness absence and disability pension benefits over followup and to support the suggestion that disability pension will become more common as time goes by (317) (318) (319) (338) (339) (341) (342) (343) (344) (345) (346) (347) (348) (349) (356) (357) (358) (359) Furthermore, a new study by Landfeldt et al 2018 was added as discusses the long term impact on treatment (to delay progression) on disability pension (375) (376) (377) (390) (391) (392) (393) (394) .
4.
It also must be made clearer that this is only a population of working age. Disposable income after 64 may look very different, and would have been interesting to include (even if the type of benefit payment changes).
Authors' response: To clarify we were only concerned with working aged population amendments have been made throughout the manuscript where appropriate to communicate the scope of our focus.
In the abstract, we added mention to working-age in the objectives, setting and in concluding on the findings (Lines 28,32 and 46). These changes were reflected in text: aim (Lines 111-114); methods and study population (Line 119); and conclusions (Line 403). As well as other mentions where necessary.
We agree that the disposable income after customary retirement age may look different and would be interesting to study. However, we did not include this age group in our analyses as was not in line with our aim. This is largely because of our interest on working aged persons and our research mandate is for this working-age population group. However, the reference Brundin et al. 2017, which was suggested, mentions how Sweden has a comparatively old MS population which adds to the potential interest in a similar such study focusing on this subgroup of the MS population and the specific sources of income which are important for this group, given different benefit entitlements. Accordingly, we have included this to the discussion where implications for future research are discussed (Lines 396-401). We believe that this placement flows well into our conclusions pertaining to the working-age population. Our interpretations of our disposable income results are based on the income sources and entitlements that the working aged population in Sweden is eligible for. The discussion focuses on the change from earnings to disability pension as the predominant source of income and the impact of this for disposable income. Importantly, one is only eligible for disability pension benefits up until the age of 64.
5.
The short follow-up time after diagnosis is the major weakness of the study, as big differences at the point in time would not be expected. With a diagnosis in 2009, was it not possible to get data to at least 2015? If 2013 was the latest year available, why not choose a diagnosis in 2006 or 2007? Some explanation/discussion would be good.
Authors' response: We agree this short time of follow-up post diagnosis is a limitation of the study, and likely why we found no differences between the MS cohort and the reference group. However, we believe there is still merit in having results suggesting that the flexible social insurance system benefits are responsive for this group of people within the first years of diagnosed MS. In addition, we included a pre-diagnosis period reflecting the progressive onset of symptoms and time lag to diagnosis.
We have amended the limitations section to more explicitly address this and explain why we chose 2009 as the diagnosis year when 2013 was the last year of data available to us (Lines 363-367). We believe that selecting this diagnosis year sought an appropriate balance between the length of followup and having a topical and relevant cohort in terms of experiencing current treatment protocols (new generation treatments were licensed for use in 2006) and reflecting current policy environment with regards to a policy change in 2008 to place stricter rules on long term sickness absence and reduced transitions to disability pension. Furthermore, we address the fact that this manuscript does not assess long-term associations of MS and economic welfare within the last point in the article summary (Lines 67-68).
The short-term lens is a limitation, as changes are expected to occur later especially with delaying treatments, but we believe our study updates knowledge of the current situation in Sweden.
6.
Considering DP and the Swedish levels of 25%/50%/75%/100%, it could be interesting to describe the distribution of these levels. I would assume that early in MS, most patients will be at 25%.
Authors' response: We agree that looking at how the grades of sickness absence and disability pension grants are distributed and develop would be interesting. However, within the LISA data the grade was not available, only the annual sum paid. The inclusion of sickness absence and disability pension was to enable an understanding of the disposable income results and aid interpretation. Accordingly our aim did not cover considering the differences in grades so explicitly.
However, we believe your comment is still very valuable for the manuscript as a potential explanation as builds from what we tried to express in the discussion about the study being early in the disease course, and yet to be so reliant on disability pension as an income source. We have revised the discussion as mentioned above and we hope we have now addressed this unique feature for Swedish insurance medicine more adequately throughout the text. For example, in the discussion we explicitly mention that we did not differentiate by grade within the limitations (Lines 373-377), and we also refer to this unique feature of part-time grants in the implications for policy (Lines 386-389).
7.
Table 2: Maybe discuss the trend for the MS group to have more SA and DP benefits 7 years prior to diagnosis? Authors' response: In light of this suggestion we both edited the presentation in text of results from Table 2 to add clarity on this trend and then elaborated on in it discussion when situating our results with previous studies. The result itself is interesting to highlight, as MS is a progressive disease with the gap between onset and diagnosis where morbidity may already affect sickness absences and also reinforces the importance of the study design to cover both pre and post-diagnosis periods. Specifically, within the results we added the mean difference of disability pension in text (Line 261), and summarized that this trend from Table 2 of MS group to have more sickness absence benefits and increasing disability pension benefits (Lines 261; (267) (268) (269) . Further, this trend for the MS group to have higher sickness absence and disability pension benefits, and increasing disability pension is further elaborated on in the discussion about the sickness absence and disability pension benefit trends and changes in light of previous findings (Lines 346-352).
8.
Table 4: For the non specialist, it may be worthwhile to explain why the totals of SA, DP and earnings don't add up, i.e. gross vs net after tax.
Authors' response: Thank you again for this observation. We interpreted this comment as referring to Table 2 where the sickness absence benefits, disability pension and earnings were presented, rather than Table 4 with results only of disposable income (the disposable income GEE model results). We agreed that clarifying gross and net will add a better understanding of the analyses in general, and the specific results for the broad readership. In reflection of this, we changed the title of the table slightly so to avoid the suggestion of these components summing to the 'whole' presented disposable income value (Line 271). A note was added to the bottom of the table (Line 272) to explain the sources and why they do not sum to the presented disposable income. In line with this, we edited the methods were we describe the outcome variables highlighting more clearly for the non-specialist the formulas and the implications of the earnings being gross and disposable income as net . We believe that by explaining gross as 'before tax' creates better consistency with the description of the disposable income outcome (unchanged) where we used the terminology 'after tax'(Lines 157 and 174).
9.
Numbers: I don't know whether presenting SEK by 100s is usual -I would find by 1000s more usual and readable, i.e. 199 instead of 1994.
Authors' response: We are grateful for your comment regarding improving the readability of the income sums presented, which are core findings of this paper. After due reflection of your comment about improving the readability and presentation of values within the tables and figures, we came to the conclusion that the most readable format would be to have the full SEK value presented. This created consistency with how the results were presented in text, and are directly useful. Whilst 1000s may lead to cleaner looking tables, and improved readability in that regard, the numbers would not be immediately meaningful for readers to interpret (whether Swedish or converting to a different currency). This is especially so as some estimates of differences between the MS and reference groups are relatively small SEK values. Accordingly, the values in Tables 2, 3 and 4 have all been changed to reflect the full SEK value in 2016.
10.
Some strengthening of the extreme skewedness of the data would be helpful for the reader (most medians are zero). Maybe cite the % from table 2 in the text?
Authors' response: Indeed the medians for annual sums of both sickness absence and disability pension are zero for the people with MS and the reference group for all years of follow-up. It is important to for the reader to realize that although the sickness absence and disability pension benefits are important sources and increasingly so for the MS group as work incapacity increases along disease progression, that most individuals in both the MS and reference group did not receive incomes from these sources. In line with your suggestion we reported the percentages in text to highlight how the skewness differed across the two study groups, despite both having a median of 0. Accordingly, we hope to have achieved clearer communication of this skewness though reformulation in the paragraph reporting Table 2 in the results section (Lines 263-265), and discussion (Lines 341-342) accordingly.
11.
Finally, page 12 lines 37-8: suggest to delete that sentence, as in view of the skewedness of the data this could be misleading.
Authors' response: Thank you for bringing to our attention the potential for this sentence to mislead in light of the skewedness of the data. We have in accordance with your suggested deleted this sentence in the revised manuscript as we do not intend to mislead the reader.
12. Finally, suggest to replace reference 6 with the reference to Brundin et al, MS Journal, supplement August 2017. Similar data, but more recent.
Authors' response: Thank you for brining to our attention our oversight in updating this reference. Accordingly, we have replaced the older reference with the similar and more up-to-date findings and estimates from Brundin et al 2017. The sentences where this older reference were cited have been amended accordingly to reflect this article's content (Lines 71-73), as well as other sentences added or amended to complement the flow and narrative after reflecting upon this article's findings in the introduction 78; (82) (83) and discussion (398) (399) (400) . In addition to this reference we added several new references as mentioned above on physical disability and cognitive function and associations to work capacity and incomes, and a reference about normality requirements when considering large health data. The combination of which we hope strengthens our narrative.
